NR 565 Final Exam Questions – Pharmacology 2022
NR 565 Final Exam Questions – Pharmacology 2022 1. What the usual daily adult dosing of Metronidazole? 1000 mg 2. The MOA of Bigunaides? Decreases glucose production by liver, increases tissue response to insulin 3. The MOA of Sulfonyureas? Promotes insulin secretion by pancreas 4. The MOA of Thiazolidinediones? Decrease insulin resistance by increasing glucose uptake and decrease Glucose 5. Contraindications of Thiazolidinediones? Patients with bladder cancer or history of bladder cancer 6. Which class of oral hypoglycemic medication is highest risk for hypoglycemia? Sulfonyureas 7. At what A1C do we start insulin? 10 8. When might an increase in insulin dose be needed? Infection, stress, abdominal growth spurt 9. When drawing up insulin which should be drawn up first? Regular, then NPH 10. How do you calculate total daily dose (TDD)? 0.2 TO 0.6 units/kg/day 10. How frequently should we monitor A1C until stable? 3 months 11. What COPD severity are combination LAMA/LABA or IGC/LABA used? Severe 12. What vaccinations are recommended at 4 months
Geschreven voor
- Instelling
- Nr 565
- Vak
- Nr 565
Documentinformatie
- Geüpload op
- 23 augustus 2022
- Aantal pagina's
- 11
- Geschreven in
- 2022/2023
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
increases tissue respons
-
nr 565 final exam questions – pharmacology 2022 1 what the usual daily adult dosing of metronidazole 1000 mg 2 the moa of bigunaides decreases glucose production by liver